지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2014.1
- 수록면
- 273 - 280 (8page)
이용수
초록· 키워드
오류제보하기
The development of cancer chemotherapy made a significant progress in cancer treatment. However, most chemotherapeutic drugs are challenged by drug resistance and drug-induced toxicity. Combination therapy has been suggested as an effective strategy to avoid drug resistance and reduce toxicity derived from drug, thereby enhancing clinical treatment of cancer. Many food-derived bioactive compounds have exhibited anticancer activity and can be good candidates for combination therapy with existing chemotherapeutic drugs. Curcumin is one of compounds that present anticancer activity in many types of cancer and has been extensively studied for its anticancer mechanisms including inhibition of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-${\kappa}B$) activation. Combinational treatment of curcumin enhanced therapeutic efficacy of traditional chemotherapeutic drugs, cisplatin, doxorubicin, 5-fluorouracil, and gemcitabine. NF-${\kappa}B$ is a major downstream effector that leads to chemoresistance of many therapeutic drugs. Down-regulation of NF-${\kappa}B$ by curcumin is an effective mechanism to sensitize chemotherapeutic drugs and increase therapeutic efficacy. Therefore, combination use of curcumin and available anticancer drugs has great potential to enhance chemotherapy efficacy and improve clinical treatment of cancer. More studies will be required to elucidate cause effect relationship of curcumin-induced suppression of cell survival pathways and enhancement of drug efficacy by curcumin.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청이 논문의 저자 정보
최근 본 자료
댓글(0)
0